Trial Details
TERMINATEDBasic Information
| Clinical ID | c1570 |
|---|---|
| Identifier | NCT01706159 |
| Trial Title | A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammation|Ulcerative Colitis |
| Interventions | DRUG: catridecacog|DRUG: placebo |
Participant Information
| Sponsor | Novo Nordisk A/S |
|---|---|
| City | Rousse |
| Country/Region | Bulgaria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-10-12 |
|---|---|
| Primary Completion Date | 2025-07-13 |
| Completion Date | 2025-07-13 |